KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 80 filers reported holding KEROS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $697,949 | -20.1% | 21,893 | +0.7% | 0.01% | -25.0% |
| Q2 2023 | $873,674 | +8.8% | 21,744 | +15.6% | 0.01% | +14.3% |
| Q1 2023 | $802,974 | -10.5% | 18,805 | +0.6% | 0.01% | -12.5% |
| Q4 2022 | $897,350 | +70.0% | 18,687 | +33.3% | 0.01% | +60.0% |
| Q3 2022 | $528,000 | +34.0% | 14,022 | -1.7% | 0.01% | +25.0% |
| Q2 2022 | $394,000 | -70.6% | 14,262 | -42.2% | 0.00% | -73.3% |
| Q1 2022 | $1,342,000 | -15.3% | 24,671 | -8.9% | 0.02% | -16.7% |
| Q4 2021 | $1,584,000 | +40.1% | 27,071 | -5.3% | 0.02% | +63.6% |
| Q3 2021 | $1,131,000 | -13.2% | 28,599 | -6.8% | 0.01% | -8.3% |
| Q2 2021 | $1,303,000 | – | 30,687 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,412,705 | $99,652,000 | 10.82% |
| CHI Advisors LLC | 433,852 | $30,604,000 | 8.62% |
| VR Adviser, LLC | 672,306 | $47,424,000 | 6.97% |
| Consonance Capital Management LP | 557,095 | $39,297,000 | 3.67% |
| Logos Global Management LP | 450,000 | $31,743,000 | 2.72% |
| RA Capital Management | 1,875,000 | $132,263,000 | 1.85% |
| Nantahala Capital Management | 534,514 | $37,705,000 | 1.17% |
| Orbimed Advisors | 1,679,417 | $118,466,000 | 1.04% |
| Eventide Asset Management | 346,000 | $24,407,000 | 0.37% |
| Atom Investors LP | 49,981 | $3,526,000 | 0.36% |